Marker Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Marker Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2025.
  • Marker Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 4, 2025 was 12.9M shares, a 45% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 12.9M +4.02M +45% Aug 4, 2025 10-Q 2025-08-14
Q1 2025 10.7M +1.81M +20.3% Mar 18, 2025 10-K 2025-03-31
Q3 2024 8.92M +34.5K +0.39% Nov 7, 2024 10-Q 2024-11-14
Q2 2024 8.92M +113K +1.29% Aug 8, 2024 10-Q 2024-08-14
Q1 2024 8.9M +104K +1.18% Mar 18, 2024 10-K 2024-03-26
Q3 2023 8.89M -74.7M -89.4% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 8.81M -74.8M -89.5% Aug 8, 2023 10-Q 2023-08-14
Q1 2023 8.8M -74.3M -89.4% Mar 17, 2023 10-K 2023-03-22
Q3 2022 83.6M +521K +0.63% Nov 1, 2022 10-Q 2022-11-10
Q2 2022 83.6M +521K +0.63% Aug 1, 2022 10-Q 2022-08-11
Q1 2022 83.1M +64.7K +0.08% Mar 1, 2022 10-K 2022-03-17
Q3 2021 83.1M +35.1M +73% Nov 1, 2021 10-Q 2021-11-10
Q2 2021 83.1M +36.5M +78.2% Aug 3, 2021 10-Q 2021-08-10
Q1 2021 83M +36.5M +78.4% Apr 30, 2021 10-Q 2021-05-12
Q3 2020 48M +2.3M +5.03% Oct 31, 2020 10-Q 2020-11-09
Q2 2020 46.6M +947K +2.07% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 46.5M +1.06M +2.34% Mar 9, 2020 10-K 2020-03-12
Q3 2019 45.7M +353K +0.78% Nov 4, 2019 10-Q 2019-11-12
Q2 2019 45.7M +32M +233% Aug 5, 2019 10-Q 2019-08-09
Q1 2019 45.5M +34.8M +328% Feb 28, 2019 10-K 2019-03-15
Q3 2018 45.4M +34.8M +331% Nov 8, 2018 10-Q 2018-11-13
Q2 2018 13.7M +3.55M +35% Aug 2, 2018 10-Q 2018-08-09
Q1 2018 10.6M +2.19M +25.9% Mar 16, 2018 10-K 2018-03-23
Q3 2017 10.5M +2.16M +25.8% Nov 1, 2017 10-Q 2017-11-14
Q2 2017 10.2M Aug 2, 2017 10-Q 2017-08-07
Q1 2017 8.44M -62.6M -88.1% Mar 13, 2017 10-K 2017-03-14
Q3 2016 8.38M Nov 2, 2016 10-Q 2016-11-04
Q1 2016 71M +38.4M +118% Apr 1, 2016 10-K 2016-04-14
Q4 2015 64.6M +45M +230% Nov 16, 2015 10-Q/A 2016-04-14
Q2 2015 46.1M Aug 1, 2015 10-Q 2015-08-14
Q1 2015 32.6M +16.6M +103% Apr 10, 2015 10-K 2015-04-15
Q4 2014 19.6M -126M -86.5% Nov 17, 2014 10-Q 2014-11-19
Q3 2014 19.1M Aug 15, 2014 10-Q 2014-08-18
Q1 2014 16.1M -76.7M -82.7% Apr 10, 2014 10-K/A 2014-04-17
Q4 2013 145M +71.5M +96.8% Nov 15, 2013 10-Q 2013-11-19
Q2 2013 129M Aug 10, 2013 10-Q 2013-08-19
Q1 2013 92.7M +36.5M +64.8% May 9, 2013 10-Q/A 2013-08-19
Q4 2012 73.9M +73.9M Nov 19, 2012 10-Q 2012-11-19
Q3 2012 72.9M +25.5M +53.8% Aug 15, 2012 10-Q/A 2012-09-12
Q1 2012 56.3M May 1, 2012 10-Q 2012-05-21
Q4 2011 0 Dec 31, 2011 10-K 2012-04-16
Q3 2011 47.4M Nov 1, 2011 10-Q 2011-11-21
Q2 2011 46.8M Aug 1, 2011 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.